LianBio (LIAN) Competitors $0.06 +0.00 (+1.41%) As of 08/29/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFDA EventsSEC FilingsTrendsBuy This Stock LIAN vs. IXHL, CTXR, BCAB, RLMD, AYTU, LEXX, FNCH, ABP, ATNF, and AIMDShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Incannex Healthcare (IXHL), Citius Pharmaceuticals (CTXR), BioAtla (BCAB), Relmada Therapeutics (RLMD), Aytu BioPharma (AYTU), Lexaria Bioscience (LEXX), Finch Therapeutics Group (FNCH), Abpro (ABP), 180 Life Sciences (ATNF), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Its Competitors Incannex Healthcare Citius Pharmaceuticals BioAtla Relmada Therapeutics Aytu BioPharma Lexaria Bioscience Finch Therapeutics Group Abpro 180 Life Sciences Ainos LianBio (NASDAQ:LIAN) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership. Which has higher valuation and earnings, LIAN or IXHL? Incannex Healthcare has higher revenue and earnings than LianBio. Incannex Healthcare is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.07Incannex Healthcare$98K197.93-$18.46M-$1.21-0.54 Does the media favor LIAN or IXHL? In the previous week, Incannex Healthcare had 8 more articles in the media than LianBio. MarketBeat recorded 8 mentions for Incannex Healthcare and 0 mentions for LianBio. Incannex Healthcare's average media sentiment score of 0.35 beat LianBio's score of 0.00 indicating that Incannex Healthcare is being referred to more favorably in the news media. Company Overall Sentiment LianBio Neutral Incannex Healthcare Neutral Is LIAN or IXHL more profitable? LianBio's return on equity of -33.17% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Incannex Healthcare N/A -342.92%-148.64% Do institutionals and insiders hold more shares of LIAN or IXHL? 74.8% of LianBio shares are held by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are held by institutional investors. 7.6% of LianBio shares are held by company insiders. Comparatively, 15.5% of Incannex Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, LIAN or IXHL? LianBio has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.67, suggesting that its share price is 667% more volatile than the S&P 500. SummaryIncannex Healthcare beats LianBio on 6 of the 11 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.21M$155.80M$5.66B$9.84BDividend YieldN/A3.78%3.93%4.04%P/E Ratio-0.0741.2983.2726.61Price / SalesN/A5,361.87451.26176.28Price / CashN/A13.1937.7059.65Price / Book0.0271.5210.556.59Net Income-$110.29M-$90.99M$3.27B$266.12M7 Day PerformanceN/A9.99%0.42%0.17%1 Month PerformanceN/A13.26%5.91%3.02%1 Year PerformanceN/A414.93%48.11%19.69% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.06+1.4%N/A-83.3%$6.21MN/A-0.07110Gap DownIXHLIncannex Healthcare0.2048 of 5 stars$0.71-4.1%N/A-64.2%$21.80M$98K-0.593High Trading VolumeCTXRCitius Pharmaceuticals2.7771 of 5 stars$1.32+4.8%$53.00+3,915.2%-90.6%$21.43MN/A0.0020Gap UpBCABBioAtla2.8695 of 5 stars$0.41+14.2%$5.00+1,129.7%-75.0%$20.91M$11M-0.3760Positive NewsGap UpHigh Trading VolumeRLMDRelmada Therapeutics4.5735 of 5 stars$0.66+6.0%$5.00+656.0%-57.6%$20.71MN/A-0.3010Positive NewsGap UpAYTUAytu BioPharma3.7063 of 5 stars$2.28-0.9%$10.00+338.6%-2.1%$20.60M$81M-3.17160Positive NewsLEXXLexaria Bioscience3.7246 of 5 stars$0.93-11.5%$4.00+330.6%-72.7%$20.54M$460K-1.397Positive NewsGap UpFNCHFinch Therapeutics Group0.2928 of 5 stars$12.70+5.9%N/A-5.0%$20.40MN/A-1.44190Gap DownABPAbproN/A$0.24-1.1%$4.00+1,550.2%N/A$19.65M$180K0.0015Positive NewsATNF180 Life Sciences0.964 of 5 stars$3.08-6.8%N/A+56.8%$18.57MN/A-0.207Gap UpAIMDAinos1.0254 of 5 stars$4.11+7.0%N/A+19.7%$17.89M$20K-0.8240Positive News Related Companies and Tools Related Companies IXHL Alternatives CTXR Alternatives BCAB Alternatives RLMD Alternatives AYTU Alternatives LEXX Alternatives FNCH Alternatives ABP Alternatives ATNF Alternatives AIMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIAN Stock Alerts